AI is quickly moving from back-office support into clinical work, including issuing prescriptions.

This blurs an important line in healthcare regulation between administrative and medical functions. It also raises a basic question for every company that builds, deploys or relies on these tools: Is an AI platform exercising medical judgment when it handles prescriptions?

Join Elizabeth Litten, Partner and Chief Privacy and HIPAA Compliance Officer, and Health Law attorneys Marc Wagner and Dylan Mason for a practical discussion about the legal landscape for AI across the prescribing life cycle, from intake and renewal to end-to-end prescribing.

Topics:

• The growing use of AI in healthcare and pharma across the country.
• The legal scope of practice and prescribing authority.
• Factors that may cause an AI-enabled platform to cross into FDA device regulation.
• Considerations for pharmacies under the FDA and state boards of pharmacy.
• HIPAA, data security and state privacy laws.
• Investments, acquisitions and commercial partnerships involving AI-enabled healthcare and life sciences companies.

This webinar is highly relevant for organizations in healthcare, pharmaceuticals, medtech, digital health and life sciences.

Speakers:
Elizabeth G. Litten, Partner and Chief Privacy and HIPAA Compliance Officer, Fox Rothschild
Marc N. Wagner, Partner, Fox Rothschild
Dylan Mason, Associate, Fox Rothschild